Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Idea Of The Day -- Ignore unavailable to you. Want to Upgrade?

To: mattie who wrote (27501)	7/13/1999 11:17:00 AM
From: IQBAL LATIF	Read Replies (1) \| Respond to of 50167

Looking nice high premiums though on the calls but worth a call above 92....Ike

To: mattie who wrote (27501)	7/13/1999 12:40:00 PM
From: IQBAL LATIF	Read Replies (1) \| Respond to of 50167

From my earlier post..I am in Adrx an interview of a guru... Q: Do you have any opinion on Sepracor Inc. (SEPR), a drug company that works to improve existing drugs? Q: I was one of the first analysts on Wall Street to recognize Sepracor's potential. It is one of my favorite specialty drug companies. There are no earnings from new drugs today, but the company is poised for huge growth in earnings in 2001. The only company likely to have a better record in the same category is Andrx Corp. (ADRX), also a terrific specialty drug and drug technology company.